Evidence map›Paper›PMID 35051108›Full record

ArticleVeterinary sciences2022

Ivermectin (IVM) Possible Side Activities and Implications in Antimicrobial Resistance and Animal Welfare: The Authors' Perspective.

Cristian Piras, Enrico Gugliandolo, Fabio Castagna, Ernesto Palma, Domenico Britti

Abstract read
In one paragraph

Article in Veterinary sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Impact of Ivermectin on the Gut Microbial Ecosystem.International journal of molecular sciences · 2023
    Article
  7. Article
  8. Potential New Therapeutic Approaches Based onAnimals : an open access journal from MDPI · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cristian PirasDepartment of Health Sciences, Campus Universitario "S. Venuta", University "Magna Græcia" of Catanzaro, Viale Europa, 88100 Catanzaro, Italy.ORCID 0000-0002-6109-0834
Enrico GugliandoloDepartment of Veterinary Sciences, University of Messina, 98168 Messina, Italy.ORCID 0000-0001-6840-3154
Fabio CastagnaDepartment of Health Sciences, Campus Universitario "S. Venuta", University "Magna Græcia" of Catanzaro, Viale Europa, 88100 Catanzaro, Italy.
Ernesto PalmaDepartment of Health Sciences, Campus Universitario "S. Venuta", University "Magna Græcia" of Catanzaro, Viale Europa, 88100 Catanzaro, Italy.ORCID 0000-0003-4199-207X
Domenico BrittiDepartment of Health Sciences, Campus Universitario "S. Venuta", University "Magna Græcia" of Catanzaro, Viale Europa, 88100 Catanzaro, Italy.ORCID 0000-0001-7355-8791

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ivermectin has a wide number of many diverse functions. Certainly, it is irreplaceable for the treatment of parasitic pathologies in both human and veterinary medicine, and the latter represents the major field of its application. It has been called the "drug for the world's poor" because of its role as a saviour for those living on the margins of society, in underdeveloped areas afflicted by devastating and debilitating diseases, such as Onchocerciasis and Lymphatic filariasis. It showed huge, unexpected potential as an antibacterial (

Indexed as

antimicrobial resistancegreen veterinary pharmacology (GVP)immunomodulationivermectinproteomics

Identifiers

PMID35051108
PMCPMC8777850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.